Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06d09aef25ab8f4c77a9291bc688f4f8 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 |
filingDate |
1995-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_058dd4ac3bf6b5259bec034f6a95034a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2315cdf35b95f82ac12145ead39ab199 |
publicationDate |
1996-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2164666-A1 |
titleOfInvention |
Tumor marker control |
abstract |
The present invention provides a stable control serum or plasma for tumor diagnosis, wherein the control contains the tumor markers relevant for the diagnosis of tumors. The serum or plasma has a reduced lipid content. The present invention also provides for a method of making the control. |
priorityDate |
1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |